4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pentixapharm Holding AG N (PTP) operates in the Biotechnology industry and is headquartered in Berlin, Germany with about 38 employees. Its market capitalization is roughly €1 million. In the fiscal year ended 2025-12-31, PTP reported €0M in revenue and (€16M) in net income.
Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €0M | €0M | €0M | €0M | — |
| Gross Profit | (€7M) | (€4M) | €5M | €4M | — |
| Operating Income (EBIT) | (€20M) | (€18M) | (€6M) | (€2M) | — |
| Net Income | (€16M) | (€13M) | (€8M) | (€2M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | €0M | €0M | €0M | €0M | €0M |
| Gross Profit | (€0M) | (€2M) | (€2M) | (€2M) | (€1M) |
| Operating Income (EBIT) | (€3M) | (€6M) | (€5M) | (€4M) | (€4M) |
| Net Income | (€3M) | (€4M) | (€4M) | (€4M) | (€4M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €42M | €68M | €73M | €54M | — |
| Total Liabilities | €7M | €18M | €25M | €15M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PTP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms